The SA Journal Diabetes & Vascular Disease Volume 17 No 2 (December 2020)

1 / 30

Featured in this issue:
Volume 17 Number 2
A Lupin Group Company
CUSTOMER CARE LINE 0860 PHARMA (742 762) / +27 21 707 7000
the endurance ACE-inhibitor
PEARINDA 4, 8. Each tablet contains 4, 8 mg perindopriltert-butylamine respectively. S3 A41/7.1.3/0649, 0650. NAM NS2 10/7.1.3/0476, 0477. For
full prescribing information, refer to the professional information approved by SAHPRA, April 2009. PEARINDA PLUS 4. Each tablet contains 4 mg
perindopril tert-butylamine and 1,25 mg indapamide. S3 A41/7.1.3/0633. NAM NS2 10/7.1.3/0611. For full prescribing information, refer to the
professional information approved by SAHPRA, April 2010. 1) The EUROPA study Investigators. “Efficacy of perindopril in reduction of cardiovascular
events among patients with stable coronary artery disease: randomized, double-blind, placebo-controlled, multicentre trial (the EUROPA study)”. The
Lancet 2003;362:782-788. 2) The PREAMI study Investigators. “Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular
remodelling and clinical outcome. Results of the randomized perindopril and remodelling in elderly with acute myocardial infarction (PREAMI) study”. Arch
Intern Med 2006;166:659-666. 3) PROGRESS Collaborative Group. “Randomised trial of a perindopril-based blood-pressure-lowering regimen among
6105 individuals with previous stroke or transient ischaemic attack”. The Lancet 2001;358:1033-41. 4) Guerin AP, et al. “Impact of Aortic Stiffness
Attenuation on Survival of Patients in End-Stage Renal Failure”. Circulation2001;103;987-992. PAI594/04/2019.
Perindopril has proven outcomes in:
• Coronary Artery Disease1
• Acute Myocardial Infarction2
• Stroke3
• End-stage Renal Failure4
Need endurance
when treating CVS disease?
November 2020
SAJDVD
The South African Journal of Diabetes & Vascular Disease
The electronic version of
the journal is available at
• Prognostic value
of admission
hyperglycaemia in
Africans with acute
coronary syndromes
• Improvement of cardiac
ventricular function by
magnesium treatment
in diabetic rat heart
• Diabesity’: interlinking
treatments to improve
outcomes in diabetes
and obesity
Reviews Research Articles Patient Leaflets Drug Trends News